The new cryoSPHERE MAX Probe, for Post-Operative Pain Management, provides increased surface area coverage and 60 second freeze cycles to optimize the efficiency of the Cryo Nerve Block procedure.
From concept to commercialization, women at AtriCure are driving innovation and shaping the future of medical technology. We're proud to celebrate their impact today and every day.
#WomeninEngineeringDay#WomeninSTEM
We honor the resilience and unwavering courage of those who have fought tirelessly against injustice; paving the way for lasting change.
#Juneteenth#FreedomDay
The LeAAPS Trial is underway and evaluating LAAE to prevent ischemic stroke in high-risk cardiac surgery patients without a history of Afib. This groundbreaking research aims to elevate patient care standards by validating LAAE's effectiveness using AtriClip devices.
Learn
The AtriClip® FLEX-Mini™ features a closed-ended design that's 60% smaller than the next lowest profile clip on the market – all while maintaining continual parallel closing pressure and stability that AtriClip devices are known for.
Discover more: https://t.co/bHH6nlTSR3
From concept to commercialization, women at AtriCure are driving innovation and shaping the future of medical technology. We're proud to celebrate their impact today and every day.
#WomeninEngineeringDay#WomeninSTEM
We honor the resilience and unwavering courage of those who have fought tirelessly against injustice; paving the way for lasting change.
#Juneteenth#FreedomDay
It’s not every day you get to meet someone whose life was impacted by your work. For AtriCure Director of Clinical Affairs, Denise, a classroom presentation turned into something unforgettable when a student shared that he had received Cryo Nerve Block Therapy for his Nuss procedure.
Moments like these remind us why we do what we do.
#PainManagement#cryoNB
Our Minnesota office was recently recognized as a Top Workplace – and for Senior Director of Product Marketing, it’s no surprise. Hear why Paul is proud to be part of AtriCure, where purpose, innovation and culture lead the way. #ThisisAtriCure
From concept to commercialization, women at AtriCure are driving innovation and shaping the future of medical technology. We're proud to celebrate their impact today and every day.
#WomeninEngineeringDay#WomeninSTEM
Our Cryo Nerve Block sales team is expanding! We are looking for experienced medical device sales professionals who are passionate about improving patient outcomes and driving product adoption.
If you have surgical selling experience and aspire to be a part of a growing, global organization, explore our current Cryo Nerve Block opportunities across the US. https://okt.to/X1nJWs
We honor the resilience and unwavering courage of those who have fought tirelessly against injustice; paving the way for lasting change.
#Juneteenth#FreedomDay
The LeAAPS Trial is underway and evaluating left atrial appendage exclusion (LAAE) to prevent ischemic stroke in high-risk cardiac surgery patients without a history of Afib. This groundbreaking research aims to elevate patient care standards by validating LAAE's effectiveness using AtriClip devices.
Learn more about LeAAPS: https://okt.to/MIl4Gs
social media channels to keep updated on the latest at AtriCure.
AtriClip FLEX∙V® Device Animation
Duration: 2:9
AtriClip PRO2® Device Animation: Mini AVR Procedure with LAA Occlusion
Duration: 3:47
Mechanism of Action Comparison AOD vs AOD2 AtriClip Devices
Duration: 1:25
AtriCure: Impacting Lives, One Patient at a Time
Duration: 6:9